The active ingredient in dozens of OTC topical acne remedies is the latest drug that an analytical laboratory which tests for potential carcinogens in finished pharmaceutical products is asking the Food and Drug Administration to remove from the US market.
Valisure LLC on 5 March submitted a citizen petition recommending the FDA request a recall and halt sales of products containing benzoyl peroxide due to the drug’s propensity to form the known human carcinogen benzene. The products include numerous topical formulations for acne treatment available through the agency’s
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?